Boston, MA -- (SBWIRE) -- 01/23/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Idera Pharmaceuticals Inc(NASDAQ:IDRA), Golden Star Resources Ltd. (USA)(NYSEMKT:GSS), MELA Sciences Inc(NASDAQ:MELA), Atossa Genetics Inc(NASDAQ:ATOS)
Idera Pharmaceuticals Inc(NASDAQ:IDRA) opened its shares at the price of $4.30 for the day. Its closing price was $4.40 after gaining +6.28% for the day. The company traded with the total volume of 4.01 million shares, while its average trading volume remained 2.66 million shares. The beta of IDRA stands at 2.03. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
For How Long IDRA will Fight for Profitability? Read This Trend Analysis report
Golden Star Resources Ltd. (USA)(NYSEMKT:GSS) closed at $0.667 with the total traded volume of 3.98 million shares, and average volume of 2.26 million. The 52 week range of the stock remained $0.39 - $1.92, while its day lowest price was $0.62 and it hit its day highest price at $0.67. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties.
Can Investors Bet on GSS after this News update? Find out in this Research Report
MELA Sciences Inc(NASDAQ:MELA) started its trading session with the price of $0.75 and closed at $0.720 by scoring +0.54%. MELA’s stocks traded with total volume of 3.75 million shares, while the average trading volume remained 482,178.00 shares. The beta of MELA stands at 0.33. Day range of the stock was $0.72 -$0.89. MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma.
Will MELA Continue To Move Higher? Find Out Here
Atossa Genetics Inc(NASDAQ:ATOS) ended its day with the gain of +17.97% and closed at the price of $3.02 after opening at $2.63. Stock traded during its last trading session with the total volume of 3.64 million shares, as compared to its average volume of 286,525.00 shares. Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States.
Why Should Investors Buy ATOS After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)